Nexalin Technology Stock Performance
| NXL Stock | USD 2.38 0.10 4.03% |
The company secures a Beta (Market Risk) of 2.82, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexalin Technology will likely underperform. Nexalin Technology right now secures a risk of 6.79%. Please verify Nexalin Technology potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if Nexalin Technology will be following its current price movements.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Nexalin Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Nexalin Technology is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return (4.03) | Five Day Return 0.85 | Year To Date Return (25.86) | Ten Year Return 5.78 | All Time Return 5.78 |
1 | Acquisition by Owens David of 2000 shares of Nexalin Technology at 2.5 subject to Rule 16b-3 | 01/13/2025 |
2 | Acquisition by Owens David of 1000 shares of Nexalin Technology at 2.7 subject to Rule 16b-3 | 01/23/2025 |
3 | Acquisition by Owens David of 1500 shares of Nexalin Technology at 2.7 subject to Rule 16b-3 | 01/28/2025 |
4 | Nexalins Breakthrough DIFS Neurostimulation Device Demonstrate | 02/03/2025 |
5 | Acquisition by Carolyn Shelton of 90620 shares of Nexalin Technology at 0.6621 subject to Rule 16b-3 | 02/10/2025 |
6 | Nexalin Technology Announces UCSD IRB Approval for use of HALO | 02/18/2025 |
7 | Nuix Ltd Earnings Call Highlights Strong ACV Growth Amidst Challenges | 02/24/2025 |
8 | Acquisition by Owens David of 139821 shares of Nexalin Technology at 0.894 subject to Rule 16b-3 | 02/26/2025 |
9 | Acquisition by White Gregory of 150 shares of Nexalin Technology subject to Rule 16b-3 | 03/06/2025 |
10 | eDiscovery Market Growth Expected to Reach 25.2 Billion by 2031 Nuix Limited, KLDiscovery Limited, CS DISCO Inc. | 03/11/2025 |
11 | Acquisition by Carolyn Shelton of 6000 shares of Nexalin Technology at 2.2 subject to Rule 16b-3 | 03/13/2025 |
12 | Will Nexalin Technology Spend Its Cash Wisely | 03/14/2025 |
13 | The Rise of Digital Forensics Market A 18.2 billion Industry Dominated by OpenText and Nuix MarketsandMarkets | 03/17/2025 |
| Begin Period Cash Flow | 580.2 K |
Nexalin |
Nexalin Technology Relative Risk vs. Return Landscape
If you would invest 262.00 in Nexalin Technology on December 22, 2024 and sell it today you would lose (24.00) from holding Nexalin Technology or give up 9.16% of portfolio value over 90 days. Nexalin Technology is generating 0.0663% of daily returns assuming volatility of 6.7923% on return distribution over 90 days investment horizon. In other words, 60% of stocks are less volatile than Nexalin, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Nexalin Technology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexalin Technology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nexalin Technology, and traders can use it to determine the average amount a Nexalin Technology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0098
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | NXL |
| Negative Returns |
Estimated Market Risk
| 6.79 actual daily | 60 60% of assets are less volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nexalin Technology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nexalin Technology by adding Nexalin Technology to a well-diversified portfolio.
Nexalin Technology Fundamentals Growth
Nexalin Stock prices reflect investors' perceptions of the future prospects and financial health of Nexalin Technology, and Nexalin Technology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nexalin Stock performance.
| Return On Equity | -2.21 | ||||
| Return On Asset | -1.23 | ||||
| Operating Margin | (105.79) % | ||||
| Current Valuation | 30.05 M | ||||
| Shares Outstanding | 13.3 M | ||||
| Price To Book | 8.98 X | ||||
| Price To Sales | 195.55 X | ||||
| Revenue | 168.72 K | ||||
| Gross Profit | 132.13 K | ||||
| EBITDA | (7.75 M) | ||||
| Net Income | (7.61 M) | ||||
| Cash And Equivalents | 291.33 K | ||||
| Cash Per Share | 0.06 X | ||||
| Total Debt | 546.69 K | ||||
| Current Ratio | 0.20 X | ||||
| Book Value Per Share | 0.28 X | ||||
| Cash Flow From Operations | (3.94 M) | ||||
| Earnings Per Share | (0.80) X | ||||
| Market Capitalization | 32.99 M | ||||
| Total Asset | 4.22 M | ||||
| Retained Earnings | (84.65 M) | ||||
| Working Capital | 3.41 M | ||||
About Nexalin Technology Performance
By examining Nexalin Technology's fundamental ratios, stakeholders can obtain critical insights into Nexalin Technology's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nexalin Technology is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 1.7 K | 1.8 K | |
| Return On Tangible Assets | (1.92) | (2.02) | |
| Return On Capital Employed | (2.11) | (2.00) | |
| Return On Assets | (1.80) | (1.89) | |
| Return On Equity | (2.07) | (1.97) |
Things to note about Nexalin Technology performance evaluation
Checking the ongoing alerts about Nexalin Technology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nexalin Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nexalin Technology had very high historical volatility over the last 90 days | |
| Nexalin Technology has high likelihood to experience some financial distress in the next 2 years | |
| Nexalin Technology has 546.69 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Nexalin to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 168.72 K. Reported Net Loss for the year was (7.61 M) with profit before taxes, overhead, and interest of 132.13 K. | |
| Nexalin Technology has about 291.33 K in cash with (3.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: The Rise of Digital Forensics Market A 18.2 billion Industry Dominated by OpenText and Nuix MarketsandMarkets |
- Analyzing Nexalin Technology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nexalin Technology's stock is overvalued or undervalued compared to its peers.
- Examining Nexalin Technology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nexalin Technology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nexalin Technology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nexalin Technology's stock. These opinions can provide insight into Nexalin Technology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share | Quarterly Revenue Growth 0.323 | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.